Alva Review-Courier -

AstraZeneca COVID-19 vaccine study paused after one illness

 

September 9, 2020



Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot.

In a statement issued Tuesday evening, the company said its "standard review process triggered a pause to vaccination to allow review of safety data."

AstraZeneca didn't reveal any information about the possible side effect except to call it "a potentially unexplained illness." The health news site STAT first reported the pause in testing, saying the possible side effect occurred in the Unite...



For access to this article please sign in or subscribe.



 

Reader Comments
(0)

 
 

Our Family of Publications Includes:

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2020